ISCHEMIA's Ripple Effects and Where They Leave Cardiologists
Partner News | Published: Monday, February 3, 2020 6:00 am
According to the CDC, heart disease is the leading cause of death worldwide, and coronary artery disease (CAD) is the most common type of heart disease. With such widespread prevalence and risk, accurate diagnosis is critical. Until recently, the primary diagnostic test for this deadly disease has been stress testing -- predominantly myocardial perfusion imaging (MPI) -- which assesses blood flow to help determine if an artery in the heart is clogged or narrowed, leading to myocardial ischemia.
While we wait for the published details of the ISCHEMIA trial findings to inform us more fully, many conversations have already turned toward the implications this trial will have on conventional non-invasive cardiac ischemia testing.